Bingli

TLDR

Bingli is an Antwerp-based AI patient anamnesis platform with EUR 5.4M in Series A funding from Capricorn Partners and UCB, automating the pre-consultation intake process for physicians.

Overview

Founded in 2017 in Antwerp, Bingli builds an AI-powered anamnesis platform that replaces paper intake forms with an adaptive digital conversation. Before a consultation, patients answer an AI-guided questionnaire that dynamically adapts based on their responses, producing a structured medical summary for the physician. The goal is to reduce consultation overhead and improve diagnostic quality.

With EUR 5.4M from Capricorn Partners and pharmaceutical company UCB, Bingli has strong institutional backing in the Belgian life sciences and digital health ecosystem. UCB's involvement signals potential for integration with pharmaceutical and clinical research workflows beyond primary care.

Funding History

• Series A: EUR 5.4M from Capricorn Partners and UCB

Key People

• Tom Van De Putte - Founder and CEO